569 results on '"Park, Margaret"'
Search Results
2. Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort
3. Abstract 12375: Performance of Echocardiographic Measures of Right Ventricular Assessment Against Cardiac MRI in Pulmonary Hypertension - Results From the PVDOMICS Cohort
4. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
5. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
6. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.
7. Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.
8. Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension
9. The effect of germline DNA repair mutations on radiosensitivity in pancreatic ductal adenocarcinoma.
10. Abstract B109: Reinforcing risk prediction for intraductal papillary mucinous neoplasms of the pancreas with AI-optimized nucleotide-to-amino acid analyses
11. Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.
12. CCAR-1 works together with the U2AF large subunit UAF-1 to regulate alternative splicing
13. RIGHT VENTRICULAR VOLUME INTER-READER VARIABILITY INCREASES WITH VENTRICULAR DILATION: RESULTS FROM THE PVDOMICS STUDY
14. Fatty Acid Metabolism
15. Fatty Acid Metabolism
16. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension
17. Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
18. Text-based Integration of Mutational Profiles for Classification and Biomarker Identification of Intraductal Papillary Mucinous Neoplasms of the Pancreas
19. Left Atrial Strain May Predict Thrombus Formation in Patients With Transthyretin Cardiac Amyloidosis
20. Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells
21. Translational relevance of SOS1 targeting for KRAS ‐mutant colorectal cancer
22. Supplementary Figures S1-S7 from SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non–Small Cell Lung Cancer Cells
23. Sleep and circadian variability in people with delayed sleep–wake phase disorder versus healthy controls
24. Insomnia in Parkinson’s Disease
25. Data from Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
26. Supplementary Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
27. Data from MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism
28. Supplementary Data from Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
29. Data from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
30. Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
31. Supplementary Fig. from MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism
32. Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
33. Supplementary Material from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95
34. Data from Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis
35. Data from Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
36. Data from Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway
37. Supplemental Figures and Tables from Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis
38. Supplemental Figure Legends from Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis
39. Supplementary Figures 1-18 from Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
40. Supplemental Methods from Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis
41. Supplementary Figures 1-8 from Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway
42. DEFINITION, PREVALENCE AND PATHOPHYSIOLOGIC ROLE OF IRON DEFICIENCY IN PULMONARY VASCULAR DISEASE
43. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
44. Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
45. Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms
46. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms
47. The translational role of SOS1 in colorectal cancer
48. Sleep Complaints and Incident Disability in a Community-Based Cohort Study of Older Persons
49. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update
50. Vascular Sonography – Educational Resources
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.